A team of cancer scientists in Pune are researching a unique nanorobot technology that can specifically target a tumour without damaging healthy cells of other organs. Unlike chemotherapy, which affects the healthy organs and cells of cancer patients, the nanorobot will be able to deliver the anti-cancer drug right inside the tumour and prevent any damage to the rest of the body.

The research has been funded by the Department of Bio Technology (DBT), Government of India, and is being spearheaded by Dr Shashwat Banerjee, 43, who heads the Central Research Laboratory at Maharashtra Institute of Medical Education and Research (MIMER) in Pune, and Dr Jayant Khandare, professor in school of pharmacy, MIT-WPU, Pune. The team has already applied for patent rights.